Pharmaceutical robots are identified as artificial intelligence robots extensively utilized across a wide range of applications within the pharmaceutical industry. These robots offer significant advantages by automating tasks, reducing the need for manual labor, and saving time and effort. Their ability to provide precise and automated operations enhances accuracy levels. Overall, pharmaceutical robots contribute to improved operational efficiency and productivity within the pharmaceutical sector.
According to Data Bridge Market Research, the Pharmaceutical Robots Market accounted for USD 130.38 million in 2022, would rise to USD 263.64 million by 2030, and is expected to undergo a CAGR of 9.20% during the forecast period 2023 to 2030.
“Increasing partnerships for pharmaceutical robots in cell treatment automation”
The market for pharmaceutical robots is experiencing significant growth due to the increasing number of partnerships between market players. For instance the collaboration between Multiply Labs, Thermo Fisher Scientific, and Charles River Pharmaceuticals to automate cell treatment production. Via leveraging cutting-edge technology, Multiply Labs aims to automate manual processes involved in cell therapy production, accelerating efficiency and advancing the field. This strategic partnership fosters market expansion and paves the way for further advancements in pharmaceutical robotics.
What restraints the growth of the pharmaceutical robots market?
“Potential failure of computer programs”
A significant restraint in the pharmaceutical robots market is the potential failure of computer programs that control these robots. Computer program failures can occur unexpectedly, leading to operational disruptions and downtime. Such failures can result in delays in production, potential errors in medication preparation or packaging, and overall loss of productivity. Addressing this restraint requires robust software development, regular system maintenance, and effective backup systems to minimize the risk of program failures and ensure uninterrupted operations.
Segmentation: Pharmaceutical Robots Market
The pharmaceutical robots market is segmented on the basis of product type, application, and end user.
- On the basis of product type, the pharmaceutical robots market is segmented into traditional robots, collaborative pharmaceutical robots.
- On the basis of application, the pharmaceutical robots market is segmented into picking and packaging, inspection of pharmaceutical drugs, laboratory applications
- On the basis of end user, the pharmaceutical robots market is segmented into pharmaceutical companies, research laboratories.
Regional Insights: North America dominates the Pharmaceutical Robots Market
North America's dominance in the pharmaceutical robots market is attributed to the strong presence of local pharmaceutical companies, especially in countries like Japan. Additionally, the region benefits from the substantial local presence of top pharmaceutical companies. The high penetration of pharmaceutical robots in North America is expected to continue growing due to the presence of numerous pharmaceutical companies in the region.
Asia-Pacific is anticipated to experience significant growth in the pharmaceutical robots market due to the presence of global pharmaceutical companies, particularly in the United States. The region also exhibits a high adoption rate of production automation. These factors contribute to the growth and adoption of pharmaceutical robots in the Asia-Pacific region.
To know more about the study visit, https://www.databridgemarketresearch.com/es/reports/global-pharmaceutical-robots-market
Recent Developments in Pharmaceutical Robots Market
- In 2021, ABB responded to the growing demand for automated production by introducing two new robots to its portfolio. The company experienced a significant surge in robot sales in China, with a reported 90% increase by the end of 2020. ABB also plans to utilize collaborative robots (cobots) to meet the rising demand in the pharmaceutical industry.
The Prominent Key Players Operating in the Pharmaceutical Robots Market Include:
- Kawasaki Heavy Industries Ltd. (Japan)
- FANUC Corporation (Japan)
- KUKA AG (Germany
- Mitsubishi Electric Corporation (Japan)
- ABB (Switzerland)
- DENSO CORPORATION (Japan)
- Seiko Epson Corporation (Japan)
- Marchesini Group S.p.A (Italy)
- Universal Robots A/S (Denmark)
- Yaskawa Electric Corporation (Japan)
- Shibuya Corporation (Japan)
- Remtec Automation, LLC (U.S.)
- Gridbots Technologies Private Limited (India)
- Lockheed Martin Corporation (U.S.)
- Robert Bosch GmbH (Germany)
Above are the key players covered in the report, to know about more and exhaustive list of pharmaceutical robots market companies contact, https://www.databridgemarketresearch.com/es/contact
Research Methodology: Global Pharmaceutical Robots Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
